reference/21022825

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21022825

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	1936-5233
issueIdentifier	2
pageRange	100983-
publicationName	Translational Oncology
startingPage	100983
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_eb4f340a1767b2ff28113b9d3c67834b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_aa048e23fd0358a0129a26ab8c57f3bb http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c3b03710945330c420364f6bff7af73d
bibliographicCitation	Younes AI, Barsoumian HB, Sezen D, Verma V, Patel R, Wasley M, Hu Y, Dunn JD, He K, Chen D, Menon H, Masrorpour F, Gu M, Yang L, Puebla-Osorio N, Cortez MA, Welsh JW. Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity. Translational Oncology. 2021 Feb;14(2):100983. doi: 10.1016/j.tranon.2020.100983.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c63ee3b64540ea37d1ba36e807e21d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_650b9169c59e459b28fe097beaeb83f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8115499741f7a6cd852f961ca8e0430 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a0048d4bf35d51b0755556e98d0af55 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c063ff70a2d0dcd58bd8c0f554cf8d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e16fd04ff701cbf9ee0a9196ccdf21ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f3346cc197d6b521434301db99cd652 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c08142bcdb0b482d1f14cd85af8f1cc6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95fba1e04cadc3d819f05ee14738d403 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5684-1405 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_297de6497e1191d5def58e6120dfc795 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1746-4624 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4505-2280 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0ded5d5aee4ac1849d09ebb34b5296c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb679f9ec0188d9b5138b8490db5e0d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1d026c11cad710fef8158584337261f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0fe97bd8447395bbc52ccdee3f2610f0
date	202102
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC7750418 https://pubmed.ncbi.nlm.nih.gov/33340886 https://doi.org/10.1016/j.tranon.2020.100983
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/34574 https://portal.issn.org/resource/ISSN/1936-5233
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a73b4feef7226074b49b42d83fadea5b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6650 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1f7f38b46f75329e1e8480a6f48ee818 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7306 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_beda6fe677b7a43d27c994ffcbd5e2d6

Showing number of triples: 1 to 46 of 46.